Meghan M. Heberton, MD, FAAD
SESSIONS
U056 Update on Cutaneous Reactions to Targeted and Immune Cancer Therapy
Mar 10, 2024
•
7:00 AM - 12:00 AM
•
Room 1B
DISCLOSURES
Astellas Pharma US, Inc – Consultant (1099 relationship)(Fees); Blueprint Medicines – Advisory Board(Fees); Revolution Medicines – Advisory Board(Fees);